Dr. Harsh Bal

Cross-border M&A, capital raising (debt/equity), consulting, relationship and alliance brokering across India and ROW. Provide services and expertise across drug discovery and development value chain - contract services, product licensing, R&D collaborations, recruiting, etc. Invite businesses seeking to set up presence in India to contact us for help with funding, operational and regulatory issues.

Strategy & technology management consulting: Advise clients in industry (Pharmaceuticals|Biotech|Life Sciences|Healthcare|IT|Consumer|…) and in Federal Government (NIH|NCI|CDC|FDA) on strategic, regulatory, financial & operational issues.

Developed an informatics platform for biomarker discovery & performed extensive gene expression studies on aberrant signaling pathways in HIV/AIDS & Leukemia using the GeneChip (Affymetrix) and Massively Parallel Signature Sequencing platforms (Solexa).

Designed and implemented a KM system around a scientific findings capture process to leverage institutional knowledge and organizational memory around Millennium’s priority genes and targets. The KM system was built on an interoperable J2EE/web services architecture that stored scientific data on a Documentum eContent Server and exchanged data and services with proprietary knowledge repositories using XML based protocols such as SOAP.

Performed comparative genomics analysis between the model plant genome – Arabidopsis - and the important food crop rice. Annotated several rice BACs for chromosome 5.

Designed adenoviral penton-based gene delivery system targeting cell-surface integrin receptors.

Designed antibody-toxin conjugates based on the human pancreatic ribonuclease for targeted therapy.